Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular tranexamic acid for blood loss reduction in total hip arthroplasty
2024-517398-26-01Phase 2Completed
- Sponsor
- Capital Region of Denmark
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tranexamic acid in osteoarthritis (OA), sponsored by Capital Region of Denmark. Primary endpoint: Total blood loss 24 hours after the operation. Started Oct 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-517398-26-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517398-26-01.